Valeant Pharmaceuticals Intl (VRX) Holder Intact Investment Management Cut Its Holding; Weatherford International Plc (WFT) Market Valuation Declined While Capital Guardian Trust Company Cut Its Position by $10.52 Million

May 18, 2018 - By Winifred Garcia

Weatherford International plc (NYSE:WFT) Logo

Intact Investment Management Inc decreased its stake in Valeant Pharmaceuticals Intl (VRX) by 19.6% based on its latest 2017Q4 regulatory filing with the SEC. Intact Investment Management Inc sold 30,600 shares as the company’s stock declined 28.77% with the market. The institutional investor held 125,500 shares of the health care company at the end of 2017Q4, valued at $3.28M, down from 156,100 at the end of the previous reported quarter. Intact Investment Management Inc who had been investing in Valeant Pharmaceuticals Intl for a number of months, seems to be less bullish one the $7.70 billion market cap company. The stock decreased 0.23% or $0.05 during the last trading session, reaching $22.03. About 7.76 million shares traded. Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has risen 42.00% since May 18, 2017 and is uptrending. It has outperformed by 30.45% the S&P500.

Capital Guardian Trust Company decreased its stake in Weatherford International Plc (WFT) by 75.78% based on its latest 2017Q4 regulatory filing with the SEC. Capital Guardian Trust Company sold 2.63M shares as the company’s stock declined 40.15% with the market. The institutional investor held 840,349 shares of the metal fabrications company at the end of 2017Q4, valued at $3.50 million, down from 3.47M at the end of the previous reported quarter. Capital Guardian Trust Company who had been investing in Weatherford International Plc for a number of months, seems to be less bullish one the $3.57B market cap company. The stock increased 0.56% or $0.02 during the last trading session, reaching $3.58. About 19.05 million shares traded. Weatherford International plc (NYSE:WFT) has declined 63.21% since May 18, 2017 and is downtrending. It has underperformed by 74.76% the S&P500.

Capital Guardian Trust Company, which manages about $7.06B US Long portfolio, upped its stake in Eli Lilly And Co (NYSE:LLY) by 338,246 shares to 693,428 shares, valued at $58.57 million in 2017Q4, according to the filing. It also increased its holding in Juno Therapeutics Inc (NASDAQ:JUNO) by 56,890 shares in the quarter, for a total of 890,585 shares, and has risen its stake in Enbridge Inc (NYSE:ENB).

Analysts await Weatherford International plc (NYSE:WFT) to report earnings on July, 27. They expect $-0.17 earnings per share, up 39.29% or $0.11 from last year’s $-0.28 per share. After $-0.19 actual earnings per share reported by Weatherford International plc for the previous quarter, Wall Street now forecasts -10.53% EPS growth.

Among 35 analysts covering Weatherford International Ltd. (NYSE:WFT), 25 have Buy rating, 0 Sell and 10 Hold. Therefore 71% are positive. Weatherford International Ltd. had 120 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was upgraded by Guggenheim on Friday, July 24 to “Buy”. The firm earned “Outperform” rating on Friday, February 5 by Cowen & Co. BMO Capital Markets maintained Weatherford International plc (NYSE:WFT) rating on Thursday, August 3. BMO Capital Markets has “Outperform” rating and $5.5 target. The rating was upgraded by Susquehanna to “Positive” on Tuesday, October 27. The stock of Weatherford International plc (NYSE:WFT) earned “Buy” rating by Citigroup on Thursday, May 19. The firm earned “Buy” rating on Friday, September 1 by RBC Capital Markets. Citigroup upgraded Weatherford International plc (NYSE:WFT) on Friday, December 11 to “Buy” rating. The stock has “In-Line” rating by Imperial Capital on Friday, June 24. The rating was downgraded by Barclays Capital to “Equal Weight” on Monday, January 9. The firm earned “Underperform” rating on Monday, June 13 by Bank of America.

More recent Weatherford International plc (NYSE:WFT) news were published by: Seekingalpha.com which released: “Oakmark Select Fund: Q1 2018” on April 23, 2018. Also Seekingalpha.com published the news titled: “Weatherford’s Debt Remains Untenable” on April 29, 2018. Seekingalpha.com‘s news article titled: “Weatherford Kicks The Can Down The Road” with publication date: April 23, 2018 was also an interesting one.

Investors sentiment decreased to 0.79 in 2017 Q4. Its down 0.16, from 0.95 in 2017Q3. It is negative, as 66 investors sold WFT shares while 97 reduced holdings. 51 funds opened positions while 77 raised stakes. 1.08 billion shares or 2.62% less from 1.10 billion shares in 2017Q3 were reported. Schwab Charles Inv Mngmt accumulated 4.15 million shares. Goodman Financial has 15,000 shares for 0.03% of their portfolio. Wedge Management L LP Nc reported 1.18% stake. Panagora Asset Management holds 15,743 shares. Ny State Common Retirement Fund has 2.44 million shares for 0.01% of their portfolio. Envestnet Asset Management has invested 0% in Weatherford International plc (NYSE:WFT). First Mercantile Tru invested in 36,400 shares or 0.03% of the stock. Moreover, Johnson Financial Grp has 0% invested in Weatherford International plc (NYSE:WFT). State Of Alaska Department Of Revenue has 52,000 shares for 0.01% of their portfolio. Ing Groep Nv invested in 55,000 shares or 0% of the stock. Virginia Retirement Et Al owns 15,822 shares. Wellington Mngmt Ltd Liability Partnership invested in 446,915 shares. Schneider Mgmt stated it has 4.74% in Weatherford International plc (NYSE:WFT). Glg Limited Company, New York-based fund reported 45,476 shares. Bancorporation Of America Corporation De owns 11.81 million shares.

Among 28 analysts covering Valeant Pharmaceuticals Intl (NYSE:VRX), 8 have Buy rating, 5 Sell and 15 Hold. Therefore 29% are positive. Valeant Pharmaceuticals Intl has $310 highest and $7.0 lowest target. $46.28’s average target is 110.08% above currents $22.03 stock price. Valeant Pharmaceuticals Intl had 169 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was initiated by Deutsche Bank with “Hold” on Tuesday, September 20. Guggenheim maintained the shares of VRX in report on Friday, November 6 with “Buy” rating. RBC Capital Markets maintained Valeant Pharmaceuticals International, Inc. (NYSE:VRX) on Friday, May 5 with “Sector Perform” rating. Barclays Capital downgraded Valeant Pharmaceuticals International, Inc. (NYSE:VRX) on Monday, March 21 to “Equal-Weight” rating. RBC Capital Markets maintained the stock with “Outperform” rating in Tuesday, November 3 report. As per Monday, February 26, the company rating was maintained by Canaccord Genuity. The rating was maintained by RBC Capital Markets with “Hold” on Thursday, May 10. RBC Capital Markets maintained Valeant Pharmaceuticals International, Inc. (NYSE:VRX) rating on Wednesday, May 10. RBC Capital Markets has “Sector Perform” rating and $19 target. The stock of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) earned “Buy” rating by Cantor Fitzgerald on Friday, January 19. TD Securities maintained the stock with “Hold” rating in Friday, November 3 report.

Analysts await Valeant Pharmaceuticals International, Inc. (NYSE:VRX) to report earnings on August, 14. They expect $0.78 EPS, down 25.71% or $0.27 from last year’s $1.05 per share. VRX’s profit will be $272.45M for 7.06 P/E if the $0.78 EPS becomes a reality. After $0.89 actual EPS reported by Valeant Pharmaceuticals International, Inc. for the previous quarter, Wall Street now forecasts -12.36% negative EPS growth.

Investors sentiment decreased to 0.97 in 2017 Q4. Its down 0.02, from 0.99 in 2017Q3. It worsened, as 51 investors sold VRX shares while 74 reduced holdings. 54 funds opened positions while 67 raised stakes. 169.66 million shares or 0.12% less from 169.87 million shares in 2017Q3 were reported. Bank & Trust Of Mellon owns 359,894 shares for 0% of their portfolio. Capstone Inv Advsrs Limited Liability Corporation owns 35,000 shares. Baystate Wealth Management Ltd Com accumulated 149 shares. 153,117 are held by State Street. Horizon Kinetics Ltd Liability owns 22,739 shares or 0.01% of their US portfolio. Quinn Opportunity Prtnrs Ltd reported 23,100 shares. Blair William Il invested 0.02% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Quantbot Techs LP holds 0.08% of its portfolio in Valeant Pharmaceuticals International, Inc. (NYSE:VRX) for 43,455 shares. Creative Planning invested in 0.03% or 353,656 shares. Jump Trading Lc accumulated 8,187 shares. Boothbay Fund Management Ltd Llc has invested 0.15% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Clearbridge Invs Limited Liability Company holds 2.92 million shares. Cornerstone Advsrs stated it has 160 shares. Aperio Gru Ltd Liability Com holds 0.02% or 209,621 shares. Van Eck Associates invested 0.07% of its portfolio in Valeant Pharmaceuticals International, Inc. (NYSE:VRX).

More notable recent Valeant Pharmaceuticals International, Inc. (NYSE:VRX) news were published by: Streetinsider.com which released: “Psoriasis Expert Positive on Valeant’s (VRX) Duobrii and Siliq – Deutsche Bank” on May 17, 2018, also Seekingalpha.com with their article: “Valeant: An Edge Into Earnings” published on April 24, 2018, Benzinga.com published: “Steve Sosnick’s Valeant Options Trade” on May 04, 2018. More interesting news about Valeant Pharmaceuticals International, Inc. (NYSE:VRX) were released by: Seekingalpha.com and their article: “Valeant to refinance existing credit deal” published on May 10, 2018 as well as Investorplace.com‘s news article titled: “Ackman Has a Point About United Technologies Corporation Stock” with publication date: May 18, 2018.

Since March 8, 2018, it had 3 buys, and 0 sales for $876,370 activity. 30,000 Valeant Pharmaceuticals International, Inc. (NYSE:VRX) shares with value of $481,500 were bought by PAPA JOSEPH C. 10,000 Valeant Pharmaceuticals International, Inc. (NYSE:VRX) shares with value of $153,400 were bought by DE SCHUTTER RICHARD U.

Intact Investment Management Inc, which manages about $2.49B US Long portfolio, upped its stake in Pattern Energy Group Inc (NASDAQ:PEGI) by 662,200 shares to 1.15M shares, valued at $30.85 million in 2017Q4, according to the filing. It also increased its holding in Canadian Natl Ry Co (NYSE:CNI) by 164,300 shares in the quarter, for a total of 638,899 shares, and has risen its stake in Transcanada Corp (NYSE:TRP).

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts